Additional investigation will be needed to fully understand the mechanism by which MO-OH-Nap induces ER stress and the UPR and to determine whether the observed differences in sensitivity of the tested myeloma cell lines to MO-OH-Nap corresponds to known differences in factors such as p53 status or whether other factors are involved. This evidence concerns the gene TP53 and plasma cell myeloma.